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a b s t r a c t
Infectious Bursal Disease Virus (IBDV) causes a highly relevant poultry disease that affects young
chickens causing, among other effects, immunosuppression. IBDV is a bi-segmented double stranded
RNA virus. The smaller ORF of larger RNA segment encodes VP5, a 17-kDa non-structural protein.
Although it is an important protein for viral replication cycle, the deﬁnition of its speciﬁc role and
subcellular localization remains unclear.
In the present work we demonstrate, using imaging techniques, that VP5 is not a type II
transmembrane protein but an intracellular membrane-associated protein. This ﬁnding might provide
evidences of VP5 interaction with cellular proteins and its functions.
& 2015 Elsevier Inc. All rights reserved.
Introduction
Infectious Bursal Disease Virus (IBDV), a member of the
Birnaviridae Family, genus Avibirnavirus, is an endemic agent in
most poultry producing areas worldwide. IBDV causes an acute,
highly contagious, immunosuppressive disease in chickens (Dobos
et al., 1979).
IBDV is a bi-segmented double stranded RNA virus. Its
genome is enclosed within a non-enveloped icosahedral cap-
sid. The short segment of the genome (B) encodes the viral RNA
polymerase (VP1). The large segment (A) contains two partially
overlapping open reading frames (ORFs). The larger ORF
encodes a precursor polyprotein that can be cleaved by the
protease VP4 to form VP2 and VP3 (Azad et al., 1985; Hudson
et al., 1986). These two structural proteins are found in the
viral capsid (Dobos et al., 1979). The smaller ORF encodes VP5,
a 17-kDa non-structural protein which is highly basic, cysteine-
rich and vastly conserved among serotype I isolates of IBDV
strains. This protein is not present in the virion but can be
detected in IBDV-infected cells. Many authors have studied
VP5; nevertheless, the deﬁnition of its role remains controver-
sial. Liu and Vakharia (2006) showed that VP5 inhibits apop-
tosis at early stages of viral infection. Later, Wei et al. (2011)
determined that the inhibition of apoptosis is given by the
interaction of VP5 with PI3K and the subsequent activation of
the effector Akt signaling pathway. On the other hand, Li et al.
(2012) demonstrated that VP5 acts as the main viral apoptosis
inducer interacting with mitochondrial ionic channels, and Wu
et al. (2009) observed that the lack of VP5 expression affects
viral release from infected cells but does not prevent intracel-
lular virus production. In another study, Lombardo et al.
showed that VP5 induces cell lysis. They also studied VP5
subcellular localization utilizing three different expression
systems and they detected the protein associated with the
Golgi system and the plasma membrane. Employing two in
silico topology prediction programs the authors proposed that
VP5 is a type II transmembrane protein with the N-terminal tail
in the intracellular space and the C-terminal region exposed to
the extracellular space (Lombardo et al., 2000).
In order to evaluate VP5 topology within the membrane, we
utilized the ﬂuorescence Protease Protection Assay (FPP) method
developed by Lorenz et al. (2006).
In the present work we demonstrate that VP5 is not a type II
transmembrane protein but an intracellular membrane-associated
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protein. Further analyses are necessary to determine the proteins
to which VP5 is associated within the plasma membrane of the
host cells and its signiﬁcance to the virus replication cycle.
Materials and methods
Cells and plasmids
Quail muscle clone 7 (QM-7) cells (ATCCs CRL-1962TM) were
used for all the experiments. QM-7 cells are susceptible to IBDV
infection (Irigoyen et al., 2009; Delgui et al., 2013).
To obtain VP5 gene, QM-7 cells were infected with D-78 IBDV
strain. After 48 h, RNA was extracted using a TRIZOL reagent
(InvitrogenTM). Reverse transcription was carried out using a
SuperScript III ﬁrst strain kit (InvitrogenTM) with speciﬁc VP5
reverse primer (AAGCTTCTCAGGCTTCCTTGGAAG). The obtained
cDNA was used as template for PCR to amplify VP5 complete gene
adding forward primer (GAATTCAATGGTTAGTAGAGATCAGAC). The
ampliﬁed product was inserted into the pTOPOs–TA vector (Life
Technologies) (pTOPO-VP5). Then, VP5 was excised and inserted
into pcDNA 3 (InvitrogenTM) vector using HindIII and XbaI restric-
tion enzymes (pcDNA-VP5). CFP was obtained from vector pECFP
(PT3258-5, Clontech) using XbaI, restriction enzyme and cloned
into pcDNA-VP5 to obtain pVP5-CFP. YFP, without its stop codon,
was obtained from pTgYFPH (Maroniche et al., 2011). YFP was
excised with HindIII digestion and cloned into pcDNA-VP5 to
obtain pYFP-VP5. The right orientation of all vectors was con-
ﬁrmed by sequencing. All restriction enzymes were purchased
from New England Biolabs and digestion reactions were set up
according to manufacturer's guidelines.
Also, mCherry gene was excised from pRB-mCherry Vector (R.
Baltanas, unpubl. data) and inserted into pcDNA3 (pmCherry).
Plasmid pGP64-mCherry was kindly provided by Dr. Andrea
Peralta (Instituto de Biotecnología, INTA, Castelar, Argentina)
(Peralta et al., 2013).
Plasmid pYFP-PrP was kindly given by Dr. Holger Lorenz
(University of Heidelberg, Germany). PrP is a prionic protein that
is localized in plasma membrane and exposes its N-terminal
extreme to the extracellular space (Lorenz et al., 2006).
All vector plasmids were also sequenced to conﬁrm the
correctness of cloning process (Sequence and genotypiﬁng service,
INTA, Castelar, Argentina).
Transfection procedure
Cells were grown, transfected, and observed on 8-well chamber
slides (Nuncs Lab-Teks II chambered coverglass). QM-7 cells were
transfected with 125 ng of plasmid using lipofectamine (Gibco),
following the instructions of the manufacturer. At 24 h post-
transfection cells were observed using a Leica TCS-SP5 spectral
laser confocal microscope (Leica Microsystems GmbH, Wetzlar,
Germany).
Fluorescence microscopy and imagining
CellTracker™ CM-DiI (Life TechnologiesTM) (Texas Red mem-
brane marker) was used to stain cell membranes. Brieﬂy, QM-7
cells were washed with PBS. CM-DIL-Texas Red was rapidly added
onto the medium (ﬁnal concentration 50 μg/ml) and incubated at
room temperature for 5 min with occasional agitation. Reaction
was stopped by the addition of 1 ml of cold fetal calf serum (FCS)
and cells were washed three times in complete culture medium at
room temperature before confocal microscopic observation. We
used a Leica TCS SP5 microscope and all images were analyzed
using the Leica Application Suite X software. Laser confocal
scanning microscopy was performed utilizing a 40X oil objective
(HCX PL APO CS 40.01.25 OIL UV). The 514 nm and 458 nm lines
of the Argon laser were used for YFP and CFP excitation. The
543 nm line from the HeNe laser was employed for mCherry or
Texas Red excitation. Scanning was performed in sequential mode
when using two ﬂuorophores simultaneously to eliminate signal
bleed-through, and ﬂuorescence emission was detected with the
following channel settings: 498–540 nm for CFP, 525–600 nm for
YFP and 610–670 nm for mCherry or Texas Red. The microscope
power settings, detectors gain and scanning speed were adjusted
to optimize contrast and resolution for each individual image.
Fluorescence Protease Protection Assay (FPP)
QM-7 cells seeded in 8 well-plates (Nuncs Lab-Teks II cham-
bered coverglass) were transfected with pYFP-VP5, pVP5-CFP or
pYFP-PrP plasmid and pmCherry and FPP assay was performed as
previously described (Lorenz et al., 2006). Brieﬂy, Twenty four
hours post-transfection, the growth medium was replaced with
PBS and the cells were treated with either 50 mM digitonin (Sigma-
Aldrich) or 5 mM/ml proteinase K (InvitrogenTM) during real-time
confocal laser scanning microscopy. pYFP-PrP plasmid was kindly
gifted by Dr. Holger Lorenz (Goethe-Universität, Frankfurt, Ger-
many) and it was used as a control for the FPP assay.
Western blot assays
Protein association with membranes was analyzed by Western
blot assay. Brieﬂy, QM-7 cells were seeded in 6-wells plates to
reach 70% of conﬂuence. Then, cells were transfected with 5 μg of
pYFP-VP5, pYFP-PrP or pYFP. At 24 h post-transfection, cells were
disrupted by passing through 27 G syringe. The membrane fraction
(M) was separated from the lysate (L) by ultracentrifugation
(100,000 g, 30 min). Fractions obtained were resolved by SDS-
PAGE, transferred to a nitrocellulose membrane and detected
using rabbit anti-GFP and anti rabbit phosphatase alkaline con-
jugated antibodies (Sigmas) and NBT/BCIP (Promegas) reaction.
Results
VP5 localizes in the plasma membrane of QM-7 cells
To determine the subcellular localization of VP5 in avian cells,
QM-7 cells were transfected with the expression vectors pYFP-VP5
and pVP5-CFP. We observed that both VP5 fusion proteins loca-
lized in the plasma membrane (Fig. 1). Cells conserved their form
and size and the ﬂuorescence was constant all around the plasma
membrane, regardless the position of the ﬂuorescent protein. To
further conﬁrm the membrane localization of VP5 in our system,
cells were co-transfected with the plasmid pGP64-mCherry, which
contains the baculoviral envelope protein GP64 which localizes in
the plasma membrane of insect cells (Peralta et al., 2013) fused to
mCherry, and both VP5 CFP or YFP fusion. As it can be observed in
Fig. 1A, VP5 fusions and GP64-mCherry co-localized in the plasma
membrane of QM-7 cells. Also, CM-DIL-Texas Red membrane
marker was used to stain pVP5-CFP transfected cells. We observed
a co-localization of the ﬂuorescent marker with VP5 fusion
(Fig. 1B). In summary, we corroborated by two different assays
the cell membrane localization of VP5 in QM-7 cells.
To analyze whether VP5 is retained in the cell membrane or is
localized close to it, we co-transfected pYFP-VP5 and pRBmCherry
[a red ﬂuorescent protein under the regulation of the CMV
promoter that localizes in cytoplasm and nucleus (Maroniche
et al., 2012)] plasmids into QM-7 cells, and treated the cells with
digitonin for membrane permeabilization. In vivo imaging of the
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treated cells showed the persistence of YFP ﬂuorescence in the
membrane and the dispersion of cytoplasmic mCherry red ﬂuor-
escence, indicating that VP5 is retained in the plasma membrane
of co-transfected cells (Fig. 1C). Moreover, nuclear red ﬂuorescence
was retained in the nucleus indicating that digitonin mediated
permeabilization was restricted only to the plasma membrane.
To further corroborate our results, we transfected QM-7 cells
with pYFP-VP5, pYFP-PrP or pYFP, we disrupted the cells and
separated the membrane fraction (M) by ultracentrifugation.
Fractions were resolved by SDS-PAGE and visualized by
immunoblotting using anti-GFP antibodies (Fig. 1D). As can be
observed, both PrP and VP5 proteins are detected associated to
membranes; on the other hand, YPF is only detected in the lysate.
In this way, we are conﬁrming VP5 membrane localization.
VP5 is not a transmembrane protein
To further explore VP5 association to the plasma membrane,
we performed the FPP assay. This method is based on the
accessibility of proteases to a ﬂuorescent domain fused to a
Fig. 1. VP5 subcellular localization. (A) Cells were co-transfected with pYFP-VP5, or pVP5-CFP, and pGP64 - mCherry, a plasma membrane protein marker. In both cases, cells
were observed at 24 h post-transfection by confocal microscopy. (B) QM-7 cells were transfected with the pVP5-CFP construction. 24 h post-transfection, cells were stained
with plasma membrane speciﬁc dye CM-DIL-Texas Red. Cells were observed by confocal microscopy with adjusted parameters to each ﬂuorescent emission. (C) QM-7 cells
were co-transfected with a mCherry expressing plasmid and with pYFP-VP5. 24 h post-transfection cells were treated with 50 μM of digitonin to permeabilize plasma
membrane. Cells images were registered in real time before and after digitonin addition. The ﬁgure shows image captures at 3 and 5 s after digitonin addition. Scale bar
corresponds to 10 μm. (D) QM-7 cells were transfected with pYFP-VP5, pYFP-PrP or pYFP. At 24 h post-transfection, cells were disrupted. The membrane fraction (M) was
separated from the lysate (L) by ultracentrifugation. Fractions obtained were resolved by SDS-PAGE and detected using rabbit anti-GFP and alkaline conjugated antibodies.
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Fig. 2. Fluorescent Protease Protection Assay. (A–D) QM-7 cells were transfected with N and C-terminal VP5 fusion vectors and observed in a confocal microscope at 24 h
post-transfection. In vivo imaging was performed in real time during the addition of digitonin and/or Proteinase K in two steps. Image captures were taken every two-second
intervals. (E) The same experiment was performed with QM-7 YFP N-terminal fusion to PrP (a gene that expresses a known transmembrane protein that exposes the
N-terminal domain to the extracellular space) and pVP5-CFP co-transfection. Scale bar corresponds to 10 μm.
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protein of interest and expressed in living cells. If the protein
under study exposes the ﬂuorescent domain to the extracellular
space, the protease will proteolise it, turning off the ﬂuorescence
(Lorenz et al., 2006).
When the assay was performed on pYFP-VP5 transfected cells,
the addition of proteinase K did not affect the ﬂuorescence
observed, meaning that the amino-terminal extreme of VP5 is
not exposed to the extracellular space (Fig. 2A). As expected, when
digitonin was also added, the proteinase K had access to the
interior of the cells and digested the ﬂuorophore (Fig. 2B). Inter-
estingly, the same effect was seen when the assay was performed
on pVP5-CFP transfected cells (Fig. 2C and D), indicating that the
carboxy-terminal extreme of VP5 was not exposed to the extra-
cellular space either. On the other hand, when the assay was
performed on pYFP-PrP and pVP5-CFP cotransfected cells the
results obtained were as expected for a transmembrane protein
exposing its N-terminal extreme to the extracellular space for PrP,
while CFP from VP5-CFP fusion still remained in plasma mem-
brane (Fig. 2E). We tested the ability of the proteinase K to degrade
CFP repeating the experiment with QM-7 cells transfected with
pCFP-PrP (data not shown). In this case, again, the addition of
proteinase K digested the ﬂuorophore indicating that both YFP and
CFP can be proteolized by the protease used. Similar results were
obtained when the assays were performed using chicken embryo
ﬁbroblast (data not shown).
These results showed that neither the VP5 carboxy-terminal
nor its amino-terminal tail are exposed to the extracellular space.
In addition, in silico analysis performed on different current
available bioinformatics tools are not consistent in VP5 localization
(Table 1). Although some predictors indicate VP5 as a transmem-
brane protein, others do not. We also compared different VP5
available sequences with the transmembrane/topology prediction
algorithms and the analyses showed that all VP5 had the same
localization, regardless the aminoacid variation they could have.
We indeed tested several VP5 sequences from other strains of
IBDV and even when the apolar region showed sequence varia-
tions, we found no differences between them.
Discussion
Studying a protein localization at the subcellular level is of
great importance because this information might lead to a better
understanding of the protein function, interaction networks and
cellular signaling pathways (Stadler et al., 2013). In a recent work,
Delgui and coworkers studied the cellular localization of IBDV
protein VP3 using HeLa and QM-7 cells. They determined the key
role of all IBDV RNPs localization in early endosomal structures,
forming ministacks with outer side of Golgi apparatus membrane.
The authors, using a similar approach to the one used in this study,
also observed the cellular localization of recombinant IBDV VP3 in
QM-7 cells (Delgui et al., 2013).
In this work, we studied the in vivo subcellular localization of
IBDV VP5 in avian cells using ﬂuorescent proteins as fusion
partners. Experiments were performed with amino and carboxy-
terminal fusions due to possible interferences in the localization
and function of VP5 (Palmer and Freeman, 2004). In accordance
with previous works (Lombardo et al., 2000), we found that VP5 of
IBDV is associated with the plasma membrane when fused to
ﬂuorescent proteins either by its carboxy-terminal or amino-
terminal end (Fig. 1). As far as we know, this is the ﬁrst study
that provides the localization analysis of VP5 using in vivo imaging
and avian cells.
Next, we analyzed VP5 topology using the FPP assay (Lorenz
et al., 2006) on transfected avian cells and we found that the
carboxy- as well as the amino-terminal region of VP5 are in
contact with the cytoplasm of host cells (Fig. 2). Lombardo et al.
(2000) postulated that VP5 was a type II transmembrane protein
by following in silico prediction models that recognize VP5 as a
membrane protein based on the presence of a hydrophobic
domain, which is not a consensus for transmembrane proteins.
Our experimental results strongly support the idea that VP5 is not
a transmembrane protein but is rather associated, directly or
indirectly, to the inner face of the plasma membrane. This is a
novel unexpected result that opens new questions regarding
protein function and IBDV replication cycle. There are no reports
on transmembrane/topology predictions for VP5 from other bir-
naviruses. We found that all algorithms we used, predicted VP5
from IPNV as a protein without transmembrane domain (data not
shown).
VP5 subcellular localization and topology provides new evi-
dence for the protein interaction possibilities. The apoptotic or
anti-apoptotic role of VP5 was discussed in previous works (Liu
and Vakharia, 2006; Wei et al., 2011; Li et al., 2012). Wei et al.
demonstrated that VP5 inhibits early apoptosis by interacting with
the regulatory (p85) alpha subunit of PI3K which is located in the
plasma membrane (Mandelker et al., 2009), and the interaction
between VP5 and PI3K is critical for the apoptosis protection
phenomenon. In that regard, the fact that VP5 has no extracellular
domains expands the possibilities of interaction with PI3K by both
its C or N-terminal domains.
Current studies are focusing on the relationship between VP5
and hosts cells factors that contributes to attach the viral protein
to the internal side of the plasma membrane such us yeast double
hybrids and immunoprecipitation.
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